This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Texas MD Anderson Cancer Center and the North American Neuroendocrine Tumor Society. The University of Texas MD Anderson Cancer Center is accredited by the ACCME to provide continuing medical education for physicians.

The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 18.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

After participating in the activity, the participant should be able to:

  • Interpret the strengths and weaknesses of recent and ongoing clinical trials.
  • Provide updated research on NETs diagnosis and treatment.
  • Utilize Interventional Oncology and Nuclear Medicine where appropriate to improve patient care & outcomes.
  • Incorporate recently approved treatments into a patient treatment plan.
  • Formulate a comprehensive career plan for early career clinicians that integrates clinical, research, and practical aspects
  • Apply recent findings in diagnostic and treatment of NETS to your practice and/or research.
  • Identify different modalities of diagnosis and treatment of NETS that will result in improved patient outcomes.
  • Compare the strengths and weaknesses of the diagnosis and treatment options for Lung NETS.
  • Compare the strengths and weaknesses of the diagnosis and treatment options for GI/pNETS.
  • Compare the strengths and weaknesses of the diagnosis and treatment options for Pheochromocytoma & Paraganglioma.